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it can proceed to effectively fill in these knowledge gaps, and 
use this newfound knowledge to improve shared treatment 
decision making, patient outcomes, and ultimately optimize 
health care efficiency.
Keywords Health-related quality of life · Thoracic aortic 
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Introduction
Traditionally, long-term outcomes after cardiac surgery have 
been reported in terms of mortality, morbidity, and the recur-
rence of disease [1]. With improved outcomes following car-
diac surgery, health related quality of life (HRQoL) gains 
increasing importance for the better judgement of choosing 
the preferred treatment strategy in the individual patient. 
This specifically applies for the field of elective surgery on 
the thoracic aorta when asymptomatic patients are operated 
on prognostic grounds. The literature gives a wide view of 
the variety of HRQoL questionnaires which has been used 
and—surprisingly—are still not widely adapted in prognos-
tic research. The objective of the current review is to provide 
an overview of current insights into quality of life measure-
ments after aortic valve and thoracic aortic surgery in adult 
patients and to provide starting points for the application of 
HRQoL measurements toward the future.
Why it is important to measure HRQoL
Professional medical values and ethics have evolved since 
Hippocrates. Nevertheless, the core values are unscathed: 
the first concern of physicians is the care of their patients. It 
is the duty of physicians to listen to their patients, to respect 
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their views and give them information in a way they can 
understand [2]. In the current era, where often multiple treat-
ment modalities are available, a physician wants to deliver 
the best care for his or her individual patient, given co-mor-
bidities, treatment options, outcomes, societal costs and 
patient preferences. Quality of life as an outcome measure 
adds an important dimension to clinical outcomes, allowing 
the introduction of the concept of quality adjusted life years 
(QALY). But how accurate is physician perception of patient 
preferences and how can we best assess quality of life? In 
the domain of cardiovascular surgery and colorectal cancer 
it was demonstrated that the physician perception of patient 
preferences can differ considerably from actual patient pref-
erences [3]. It underlines the importance of gathering evi-
dence of actual patient preferences before and quality of life 
after cardiac surgery. From a patient perspective it is worth 
knowing how long it takes to recover from surgery, and if 
and when one can go back to living their life to the full-
est. Surgeons can analyze aortic root diameters, reoperation 
rates and survival, but measuring a person’s emotional state 
or physical impairment is more challenging. Tailoring the 
optimal treatment strategy to the individual patient can be 
particularly delicate in heart valve and aortic root surgery, 
as the available treatment options carry different value-sen-
sitive advantages and disadvantages such as bleeding and 
thrombo-embolic risks, reoperations risks, valve sound and 
strict anticoagulation management. There is emerging evi-
dence that patients requiring heart valve replacement want 
to be involved more in their treatment decision making and 
that involved patients are better informed, less anxious and 
depressed, and have a better mental well-being [4]. This is 
not only important for the patient: from a societal perspec-
tive it is crucial that costs of healthcare are contained, while 
achieving better outcomes. Patient empowerment—includ-
ing addressing values, preferences and quality of life—is 
thought to be one of the cornerstones of health care cost con-
tainment. Bradley et al. nicely describe the main aspects of 
‘value measurements’ in the field of cardiovascular care [5]. 
Healthcare value is defined as ‘health outcomes achieved 
relative to the costs of care’ and they underline the definition 
proposed by porter that outcomes should reflect the ‘health 
circumstances most relevant to patients’ [6].
For all the reasons mentioned above it is crucial that in 
the cardiovascular domain, with complex patients under-
going complex high-tech procedures, we put emphasis on 
measuring HRQoL in our outcomes research, and apply this 
knowledge to further improve our clinical practice.
How to measure HRQoL after cardiac surgery
Four decades ago one of the first reports on HRQoL after 
cardiac surgery was described by Ross et al. [7] Their survey 
showed an overall improvement in the quality of life for the 
majority of patients having open-heart surgery at a time that 
the field of cardiac surgery had passed beyond the develop-
ment phase into a standard practice and had gained wider 
acceptance. There are many ways to measure HRQoL. In 
the field of thoracic aortic surgery recently Jarral et al. con-
ducted a systematic review that revealed a total of 17 differ-
ent HRQoL instruments. The most commonly used generic 
HRQoL instrument was the Short Form 36-Item Health Sur-
vey (SF-36) (67% of the studies). The other instruments that 
were used in more than two studies were: hospital anxiety 
and depression score (HADS), RAND SF-36, Karnofsky 
activity scale, SF-12, illness intrusiveness rating scale, sick-
ness impact profile questionnaire and a ‘General Health per-
ception questionnaire’. EuroQOL-5D (EQ-5D), a preference-
based measure, was found in two studies. Even valve-specific 
measures were not used frequently. For example, the valve 
disturbance questionnaire, was used once [8]. Additionally, 
worth mentioning is a survey which combines HRQoL ques-
tions with functional measurements, like the Duke Activity 
Status Index (DASI) [9]. Below a short description of the 
most frequently used instruments is given:
SF‑36
The most frequently used instrument is SF-36: it is a mul-
tipurpose, short-form with 36 questions. It yields an eight-
scale profile of scores as well as physical and mental health 
summary measures. It is a generic measure, as opposed to 
one that targets a specific age, disease, or treatment group 
[10]. Although it has a generic approach, SF-36 is the most 
widely used survey in thoracic aortic surgery. In 1996 the 
SF-36 is updated in version 2. Modifications include format 
changes, wording revisions, and changes in the number of 
response choices, which resulted in greater readability, reli-
ability, and validity [11]. Moreover, the interpretation of SF-
36v2 results has been greatly simplified with the norm based 
scoring of its health domain scales and component summary 
measures. Instead of a scale from 0 to 100 the norm based 
scales refer to the deviation from the general population 
norm as these values are built into the scoring algorithm. 
An individual respondent score above 45 and group mean 
scores above 47 can be interpreted as being above the aver-
age range for the general US population. Norm scores are 
also being developed for specific age groups or countries 
outside the US [12].
Hospital anxiety and depression score (HADS)
Hospital anxiety and depression score is developed as a clin-
ical screening tool to assess anxiety and depression among 
patients in hospitals. The instrument comprises 14 questions 
and results in two sum scores: one for anxiety and one for 
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depression. Higher scores indicate more change to have a 
mood disorder. The HADS is a well-accepted, valid, and 
reliable screening tool [13].
HRQoL survey correlated with functional measurements
An example of a functional assessment based on activities 
of daily living and cardiovascular fitness, assessed using a 
self-administered questionnaire is the Duke Activity Sta-
tus Index (DASI). Peak oxygen uptake was considered the 
gold standard for cardiovascular functional capacity. DASI 
was developed by taking into account the empirical correla-
tions of questionnaire items with peak oxygen uptake, clini-
cal judgment and information from previous studies about 
the activities best representing different aspects of physical 
functioning [9].
Valve specific questionnaire
The valve-specific questionnaire determines the effects of 
valve related items such as bothersome sounds, frequency 
of medical visits, and fear of potential complications such 
as bleeding or reoperation for valve failure. It includes the 
powerful question “If I had to do it over again, would I make 
the same decision to have surgery?”, which covers a weigh-
ing of all pro’s and con’s [14].
What is known?
Several studies have studied the effect of cardiac surgery 
on HRQoL. Chocron et al. [1] compared HRQoL before 
and after open heart surgery using the Nottingham Health 
Profile. They found that HRQoL scores improved signifi-
cantly in an average of 80% of patients and 91% of patients 
reported the operation improved their lives. However, these 
outcomes apply to the general cardiac patient population, 
and not specific cardiac surgery subgroups. HRQoL scores, 
like any other outcome measure, may differ between the dif-
ferent cardiac surgery procedures. Therefore, we reviewed 
the literature on HRQoL focusing on aortic valve surgery 
and thoracic aortic surgery.
Aortic valve surgery
Mechanical valves versus tissue valves
Two studies investigating HRQoL using the SF-36, found 
that patients receiving a mechanical or tissue aortic valve 
prosthesis report comparable quality of life after their oper-
ation [15, 16]. Another two studies investigating HRQoL 
using the SF-36, found that on average tissue valve recipients 
and aortic valve repair patients report better quality of life 
than mechanical valve recipients [17, 18]. The studies com-
paring quality of life after surgery with the general popula-
tion using the SF-36 found no significant differences [16, 
19]. No associations were found between the quality of life 
scores and preoperative NYHA scores or event rates [17, 
19].
Aortic valve repair versus aortic valve replacement
A landmark study by Aicher et al. [20] compared quality 
of life after aortic valve repair and aortic valve replacement 
using mechanical valves and pulmonary autografts, using 
the SF-36, Hospital Anxiety and Depression Scale (HADS), 
Cardiac Anxiety Questionnaire (CAQ), and valve-specific 
questions. SF-36 outcomes in most domains were compa-
rable between aortic valve repair and pulmonary autograft 
patients, but significantly better in aortic valve repair com-
pared to mechanical valve replacement. No differences were 
found between the groups in the HADS, but interestingly 
compared to healthy subjects valve repair and pulmonary 
autograft patients had significantly higher anxiety scores 
while mechanical valve replacement patients did not. CAQ 
scores were comparable between the groups after correc-
tion for follow-up, but significantly worse when compared 
to healthy subjects. Concerning valve-specific questions, 
mechanical valve replacement patients were more bothered 
by valve sounds and the frequency of follow-up, and more 
concerned about failure of the valve and possible bleeding 
due to anticoagulation medication.
Thoracic aortic surgery
Quality of life after thoracic aortic surgery
Very limited information is available concerning the qual-
ity of life after thoracic aortic surgery. A study performed 
by Olsson in 1999 [21] comparing quality of life in tho-
racic aortic surgery patients to the general population using 
the SF-36, showed significantly worse HRQoL outcomes 
for patients who had thoracic aortic surgery. However, 
an updated study by Olsson in 2013 [22] using the SF-36 
showed comparable results for both groups. This difference 
could be the result of the advances in cardiac surgery and 
quality of cardiovascular care throughout the years. Two 
other studies using the SF-36, as well as the systematic 
review performed by Jarral et al., found quality of life in 
thoracic aortic surgery patients to be comparable to the gen-
eral population [8, 23, 24].
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Valve sparing aortic root surgery versus composite graft 
root replacement
Franke et al. [25] investigated the quality of life after valve 
sparing aortic root surgery and composite graft root replace-
ment using the SF-36. Patients in the replacement group had 
significantly worse quality of life outcomes in most of the 
domains of the SF-36 compared to the valve sparing group. 
In subgroup analyses for age, they found that patients under 
50 years of age or over 70 years old had significantly worse 
outcomes in most of the SF-36 domains in the composite 
graft group compared to the valve sparing group. Further-
more, composite graft patients were significantly more dis-
turbed by valve sounds, were more afraid their valve would 
fail and gave a lower score to their overall condition. Jarral 
et al. [8] reports one study that found no difference in qual-
ity of life.
Composite graft root replacement: mechanical 
versus tissue valves
Two studies [26, 27] investigated HRQoL using SF-36, 
EuroQoL, the Seattle Angina Questionnaire (SAQ), and the 
Hospital Anxiety and Depression Scale (HADS) in patients 
after composite graft root replacement, comparing mechani-
cal and tissue valves (Ross procedure and biological valves). 
Both studies found comparable HRQoL outcomes between 
the two groups for all instruments used.
Effect of self‑managing anticoagulation
A recent Cochrane review [28] found that patients self-
managing their anticoagulation medication had fewer throm-
boembolic and bleeding complications, with some studies 
even observing a reduction in mortality. Unfortunately, this 
review did not address the effect of anticoagulation self-
management on HRQoL. Pozzi et al. [29] also performed a 
systematic review on self-managing anticoagulation therapy, 
and found eight studies assessing HRQoL with regard to 
self-managing anticoagulation in both adult and pediatric 
populations. Seven studies found an improvement in the 
quality of life and general treatment satisfaction together 
with lower anxiety, distress and strain for the patient and 
their family. These observations suggest that in patients who 
require anticoagulation there is room for the improvement 
of HRQoL through self-management of anticoagulation 
therapy, although one should realize that not every patient 
may be capable of self-management and thus far cost-effec-
tiveness appears comparable to standard anticoagulation 
management [30].
The effect of baseline HRQoL on HRQoL outcome 
scores
When assessing HRQoL after thoracic aortic surgery it is 
important to take into account HRQoL before the surgery, 
especially when elective surgery is considered. Kurfirst et al. 
[31] investigated the effect of preoperative HRQoL scores 
on HRQoL outcome scores. They found that older patients 
with lower preoperative HRQoL show a score improvement 
comparable to younger patients. However, a higher preop-
erative HRQoL score was a risk factor for non-improvement 
of postoperative HRQoL scores. In concordance, Koch et al. 
[32] examined the functional health-related quality of life 
after aortic valve replacement and found a ‘ceiling effect’ 
as patients with high preoperative scores could only retain 
their HRQoL level or worsen. This suggests that patients 
with high preoperative HRQoL scores, usually the asymp-
tomatic patients, have little to gain and a lot to lose when it 
comes to HRQoL. This should be discussed with the patient 
during preoperative consultation and taken into account in 
treatment decision-making.
Time factor in studying quality of life after surgery
Another factor that may influence HRQoL after thoracic 
aortic surgery is time: HRQoL varies with time passing and 
usually declines with age. Early after surgery HRQoL is usu-
ally strongly impaired, as this highly invasive type of surgery 
has a tremendous impact on both physical and mental quality 
of life. After the first few months HRQoL will improve and 
stabilize, and next steadily decline with ageing. In addition, 
late events related to the surgical implant or to progression 
of aortic disease may have an impact on HRQoL in a time-
related fashion. Very little is known about the time-related 
variation of HRQoL after thoracic aortic surgery. Among 
the studies included in this review, only Sedrakyan et al. 
[16] performed a prospective study, in which they used one 
point in time after surgery for investigating HRQoL after 
the baseline results. The retrospective and cross-sectional 
studies investigating aortic valve surgery generally had a 
timespan between surgery and investigation of 1.5–2.5 years, 
with one study investigating HRQoL after 30 years [19]. For 
aortic surgery the mean time to HRQoL assessment was 
only 2–4 years. Therefore, it is highly recommendable that 
prospective studies are initiated comparing baseline HRQoL 
with outcome HRQoL at different points during follow-up 
within the same patient population.
Using the right tools
It is equally important to use the right tools, using different 
types of questionnaires when appropriate and where neces-
sary. The HADS [33] has been validated to be used during 
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hospital admission. The SF-36 can be used at baseline and 
during follow-up, as it gives general HRQoL information. 
In addition, it is widely used and, therefore, generalizable in 
the cardiovascular domain. Valve-specific or disease-specific 
questionnaires should be used as well, as the SF-36 lacks 
aortic valve surgery and thoracic aortic surgery specific 
issues related to HRQoL.
Time to treatment equipoise
An interesting new concept in surgical decision making 
that was recently proposed is Time To Treatment Equipoise 
(TUTE) [34]. It is a method to compare relative risks of two 
surgical approaches, for example a high risk surgical proce-
dure (10% early mortality) with a low late mortality hazard 
(1% per year) versus a low risk minimal invasive procedure 
(1% early mortality) with a higher late mortality hazard (3% 
per year). Patients who choose for the first option, are will-
ing to take an early risk to obtain better long term survival, 
while those who opt for the second option do not take an 
early risk but have to deal with a worse long-term survival. 
At some point in time (around 3 years) the survival curves 
of these two treatment strategies will cross and next diverge. 
TUTE is defined by the duration of time that elapses after 
an intervention, before the risk of the intervention is nul-
lified and reversed by the cumulative risk of conservative 
management. Ultimately, the outcome of interest that should 
be considered when determining TUTE is not survival but 
HRQoL adjusted survival, to correct for any differences in 
HRQoL outcomes between the two surgical strategies. It is 
expected that expansion of TUTE to also include HRQoL is 
just a matter of time and will provide patients and doctors 
with even better tools to weigh treatment decisions.
QALYs
Another important reason to implement HRQoL meas-
urements in clinical research and clinical care, is their 
importance in assessing the cost-effectiveness of treatment 
options. In particular in cardiovascular 21st century health-
care with steadily expanding technological advances in an 
ageing population, the containment of costs is becoming a 
holy grail [35]. When balancing risks, benefits and costs of 
treatment options in cardiothoracic interventions the consid-
eration of HRQoL is essential to be able to calculate quality 
adjusted life years (QALYs). QALYs are an essential com-
ponent of cost-utility analysis in order to estimate the cost-
per-QALY associated with a health care intervention. This 
information in turn can be utilized to calculate the incre-
mental cost-effectiveness ratio and assess whether a particu-
lar intervention is worth the investment. It is expected that 
the use of HRQoL data for health economic purposes will 
become increasingly accepted to guide resource allocation.
Future directions
Which tool to use
The SF-36 survey is currently the most popular tool in the 
field of aortic valve and thoracic aortic surgery. It remains, 
however, unknown what the effectiveness is of SF36 and 
the other available HRQoL tools in terms of compliance, 
validity and sensitivity. It is methodologically challenging 
to compare scores obtained with different instruments, even 
if they measure the same health concept. This is due to the 
dependency of individual items within a survey to come 
to a sum score. A disadvantage of sum scores is the ‘ceil-
ing effect’, patients with preoperative high HRQoL scores 
can either remain the same or worsen post-operatively [32]. 
There are alternative methods originating from educational 
sciences, where skills can be tested and compared over 
time taking into account the growing knowledge in primary 
school children. These methods are based on item response 
theory (IRT) in combination with a calibrated item bank. 
In addition, computerized adaptive testing methods can be 
implemented to keep the burden (number of question asked) 
to the patient as low as possible. This can be achieved by 
presenting difficult items to asymptomatic patients and eas-
ier items to more severely impaired patients, whilst ensuring 
that estimates of health status or HRQoL remain completely 
comparable. The application of this innovative method of 
measuring is being studied in the ‘Amsterdam linear dis-
ability score’ (ALDS) project where functional outcome is 
measured in several clinical research areas [36]. Despite the 
complexity of these methods, the use should be explored 
in the cardiac surgery domain. Furthermore, the nonprofit 
International Consortium for Health Outcomes Measure-
ment (ICHOM) developed a consensus standard set of out-
come measures for coronary artery disease (CAD) and heart 
failure (HF), where other conditions will follow. This initia-
tive could lead to further standardization [37].
Practical gaps to overcome
An important limitation in the current use of HRQoL tools 
in cardiac surgery is its retrospective nature. We need to 
implement HRQoL in prospective clinical trials, observa-
tional cohorts and institutional quality improvement pro-
grams to use these measurements prospectively to start 
continuously improving the quality of care for patients with 
aortic valve and thoracic aortic disease. A national initiative 
in the Netherlands termed ‘Meetbaar Beter’ or in English 
‘Measurably Better’ encourages participating heart centers 
to collect HRQoL pre- and post-intervention (at 1 year). The 
initiative started 5 years ago, and only 3 of the 14 affiliated 
Dutch heart centers have implemented the HRQoL sur-
veys, exposing the challenges of implementation in clinical 
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practice [38]. One of the reasons why it is not used every-
where and prospectively, is probably due to the fact it is very 
time consuming—and thus costly—to send questionnaires 
pre- and post-operatively to the patient, to trace the miss-
ing, to build a database and perform data entry. Hopefully 
in the future implementation will be facilitated by the rap-
idly evolving information technology possibilities in health 
care. One example is ‘empowering the patient’ by provid-
ing them with secure access to their own electronic medical 
files, with the ability to fill in HRQoL questionnaires online 
and store data in institutional secures data ware houses. 
While the information is stored in the medical file, it can 
be used in clinical decision making, enabling further self-
determination. Moreover, we encourage academic societies 
to share standalone tools they have developed, to empower 
research groups worldwide. When the tools are available 
through an open source, it will catalyze the improvement 
and usage of these tools through ‘networked science’ [39]. 
One of the greatest examples is the open source statistical 
software program ‘R’.
Disease specific solution for aortic valve regurgitation 
and thoracic aortic aneurysms
The AVIATOR initiative—under the umbrella of the Heart 
Valve Society (HVS)—is a start to achieve more standardi-
zation in the treatment of patients with thoracic aortic dilata-
tion, aortic valve regurgitation, or both. It is a prospective, 
multicenter, international registry that has the goal to gather 
information during the complete trajectory of the disease 
from diagnosis until long-term follow-up regardless whether 
the patient needs to be operated upon or not. The database 
is hosted in Paris and the abilities for patient-self-reported 
outcomes, is a built-in feature which can be further explored. 
Patients receive a unique access code by e-mail to fill in 
questionnaires online. The provided answers will be stored 
in the database. Participating in AVIATOR is free, provided 
that one the heart team physicians is member of the HVS. It 
enables participating centers to implement HRQoL surveys 
easily for this specific patient group. Within AVIATOR the 
debate should be encouraged to select the right measurement 
tool to measure HRQoL. The ultimate goal of AVIATOR is 
to create an evidence base to enable tailoring the most suit-
able surgical treatment strategy to individual patients with 
aortic regurgitation, thoracic aortic dilatation or both.
Conclusion
In a perfect world, patients would get the best quality of 
care with regard to outcome measures and quality of life, 
while still being socially responsible, cost-effective, ethical 
and with minimum strain on physicians and other healthcare 
professionals. Practically, this means a patient should receive 
the best evidence based treatment with the lowest mortality 
and complication rates, but also the treatment that allows the 
patient achieve their best HRQoL to live life to the fullest. 
The lowest complication rates and the best HRQoL unfor-
tunately do not always go hand in hand. Also, the valua-
tion of quantity and quality of life may vary considerably: 
for example in the growing elderly population the balance 
between quality of life and quantity of life is very delicate, 
especially toward the end of life. Our scientific community 
has the responsibility to fill in these knowledge gaps, pro-
viding the physician, the patient, and society with tools to 
carefully balance decision making.
In light of the (level of) evidence on HRQoL outcomes 
after aortic valve and thoracic aortic surgery presented 
above, it is necessary to discuss factors that may be of influ-
ence on HRQoL, and to deliberate how the cardiovascu-
lar surgery community can proceed to effectively measure 
what matters to the patient toward the future, and use this 
knowledge to improve treatment decision-making, patient 
outcomes, and ultimately optimize health care efficiency.
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